İmdat Eroğlu

8PUBLICATIONS
26CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer diagnosisHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 04, 2026
A pragmatic adaptation of the RANO clinical risk score for IDH-Wildtype glioblastoma in the absence of MGMT promoter methylation testing.

|Jul 15, 2026
Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study.

|Mar 19, 2026
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.

Mustafa Gürbüz, Deniz Tural, Timuçin Çil

|Feb 04, 2026
Compatibility of different PET/CT criteria in evaluating treatment response and survival in non-small cell lung cancer patients treated with immunotherapy.

İmdat Eroğlu, Uğuray Aydos, Yasemin Ünlüer Ateş

|Nov 12, 2025
Efficacy and safety of neoadjuvant FLOT treatment for resectable gastric/gastroesophageal junction adenocarcinoma in Turkish and German patients; a real-world data.

İmdat Eroğlu, Christian Möhring, Farsaneh Sadeghlar

|May 27, 2024
Muscle function, exercise capacity, physical activity level and cardiovascular disease risk factor knowledge in patients with prolactinoma.

Ayşegül Erkoç, İmdat Eroğlu, Tomris Erbas

Pageof 2

Frequent Collaborators

3 joint publications

Tomris Erbas

2 joint publications

Burcin Gonul Iremli

2 joint publications

Ayşegül Erkoç

2 joint publications

Ilkay S Idilman